Ratings Central China New Life Limited

Equities

Delayed Hong Kong S.E. Other stock markets 11:21:36 2024-06-06 pm EDT			5-day change	1st Jan Change
1.6 ^HKD	-2.44%		+36.75%	+4.58%

Jun. 04	Central China New Life Limited Proposes Special Dividend for the Year Ended 31 December 2023	CI
May. 06	Central China New Life Limited Announces Change of Principal Place of Business in Hong Kong	CI

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Thanks to a sound financial situation, the firm has significant leeway for investment.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.13 for the 2024 fiscal year.
The company appears to be poorly valued given its net asset value.
The company has a low valuation given the cash flows generated by its activity.
This company will be of major interest to investors in search of a high dividend stock.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
For several months, analysts have been revising their EPS estimates roughly upwards.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company's earnings growth outlook lacks momentum and is a weakness.
For the past year, analysts have significantly revised downwards their profit estimates.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
The group usually releases earnings worse than estimated.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
CENTRAL CHINA NEW LIFE LIMITED	+4.58%	268M		-
CBRE GROUP, INC.	-7.62%	25.94B		B+
KE HOLDINGS INC.	+0.06%	19.72B		C-
ZILLOW GROUP, INC.	-26.52%	10.02B		C-
CAPITALAND INVESTMENT LIMITED	-16.46%	9.84B		B-
JONES LANG LASALLE INCORPORATED	+5.38%	9.47B		B+
FIRSTSERVICE CORPORATION	-4.78%	6.72B		C-
COLLIERS INTERNATIONAL GROUP INC.	-11.47%	5.45B		B+
MAKKAH CONSTRUCTION AND DEVELOPMENT COMPANY	+28.80%	4.21B	-	-
CUSHMAN & WAKEFIELD PLC	-5.09%	2.35B		C+

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality